Itamar Medical Highlights New WatchPAT™ Scoring Guidelines Based on the COMPASS(1) Study Results from Johns Hopkins Sleep Investigators at SLEEP 2018 Evidence-based guidelines based on a large-scale sleep apnea study demonstrating WatchPAT’s efficiency and accuracy compared to standard diagnostic alternatives CAESAREA, Israel, May 30, 2018 ...

Itamar Medical reports record financial results for the first quarter, with 26% increase in revenue to $5.5 million and minimal operating loss Company advances NASDAQ ADR registration First quarter 2018 highlights Maintained gross profit of 77% of total revenuesCash basis (non-GAAP) operating loss of $0.5 millionSharp sales growth in U.S....

Itamar Medical Launches SleePath™, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool for AFib Patients at Heart Rhythm 2018 Innovative e-Health CARDIO SLEEP DASHBOARD provides timely insights into patients’ sleep status and compliance with sleep apnea therapy specially design for cardiologists needs CAESAREA, Israel, May ...

Itamar Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss - Company evaluating potential U.S. listing - Fourth Quarter 2017 Highlights Record revenues of $6 million, a 21% year-over-year increase WatchPAT™ revenues of $4 million in the U.S.Gross margin...